CareDx Stock

CareDx Gross Margin

The Gross Margin of CareDx (CDNA) as of Aug 20, 2026 is 67.55 %. In the previous year, Gross Margin was 67.16 % — a change of 0.59% (higher).

Gross Margin

67.55 %

YoY

0.59%

Last updated:

Gross Margin of CareDx is 2026 67.55 % . Gross Margin of CareDx was 2025 67.16 % . It decreases by 0.59% higher compared to the previous year.

CareDx's gross margin stands at 67.6%, broadly stable from 67.1% several years earlier.

Access this data via the Eulerpool API

CareDx Stock analysis

What does CareDx do? CareDx Inc is a US-based company specializing in diagnostic solutions for the transplantation industry. The company was founded in 1998 and is at the forefront of developing tests for transplant patients. CareDx is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CareDx stock

Gross Margin of CareDx is 67.55 % in 2026.

Gross Margin of CareDx changed from 67.16 % to 67.55 %, representing a 0.59% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin CareDx since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's CareDx with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

Margins — CareDx

All Key Metrics — CareDx